Get Real Time Here
| Open1.480 | Close1.470 |
| Vol / Avg.90.293K / 199.782K | Mkt Cap118.982M |
| Day Range1.465 - 1.500 | 52 Wk Range0.725 - 3.850 |
ProQR Therapeutics Stock (NASDAQ:PRQR), Quotes and News Summary
ProQR Therapeutics Stock (NASDAQ: PRQR) stock price, news, charts, stock research, profile.
| Open1.480 | Close1.470 |
| Vol / Avg.90.293K / 199.782K | Mkt Cap118.982M |
| Day Range1.465 - 1.500 | 52 Wk Range0.725 - 3.850 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.110 | 0.0100 | ||||
| REV | 1.350M | 1.313M | -37.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-18 | Citigroup | Yigal Nochomovitz | Maintains | BuyBuy | Lowers | 2.10 | 1.80 |
| 2023-08-07 | HC Wainwright & Co. | Andrew Fein | Reiterates | BuyBuy | Maintains | - | 5.00 |
| 2023-08-04 | Chardan Capital | Keay Nakae | Reiterates | NeutralNeutral | Maintains | - | 2.00 |
| 2023-05-17 | Cantor Fitzgerald | Jennifer Kim | Maintains | OverweightOverweight | Lowers | 5.00 | 4.50 |
How do I buy ProQR Therapeutics (PRQR) stock?
You can purchase shares of ProQR Therapeutics (NASDAQ: PRQR) through any online brokerage.
Who are ProQR Therapeutics's (PRQR) competitors?
There are no as such competitors for ProQR Therapeutics.
What is the target price for ProQR Therapeutics (PRQR) stock?
The latest price target for ProQR Therapeutics (NASDAQ: PRQR) was reported by Citigroup on Monday, September 18, 2023. The analyst firm set a price target for 1.80 expecting PRQR to rise to within 12 months (a possible 22.45% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for ProQR Therapeutics (PRQR)?
The stock price for ProQR Therapeutics (NASDAQ: PRQR) is $1.47 last updated September 22, 2023 at 7:59 PM UTC.
Does ProQR Therapeutics (PRQR) pay a dividend?
There is no dividend information for ProQR Therapeutics.
When is ProQR Therapeutics (NASDAQ:PRQR) reporting earnings?
ProQR Therapeutics’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is ProQR Therapeutics (PRQR) going to split?
There is no upcoming split for ProQR Therapeutics.
What sector and industry does ProQR Therapeutics (PRQR) operate in?
ProQR Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
ProQR Therapeutics Stock (NASDAQ:PRQR), Quotes and News Summary
ProQR Therapeutics Stock (NASDAQ: PRQR) stock price, news, charts, stock research, profile.
| Open1.480 | Close1.470 |
| Vol / Avg.90.293K / 199.782K | Mkt Cap118.982M |
| Day Range1.465 - 1.500 | 52 Wk Range0.725 - 3.850 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.110 | 0.0100 | ||||
| REV | 1.350M | 1.313M | -37.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-18 | Citigroup | Yigal Nochomovitz | Maintains | BuyBuy | Lowers | 2.10 | 1.80 |
| 2023-08-07 | HC Wainwright & Co. | Andrew Fein | Reiterates | BuyBuy | Maintains | - | 5.00 |
| 2023-08-04 | Chardan Capital | Keay Nakae | Reiterates | NeutralNeutral | Maintains | - | 2.00 |
| 2023-05-17 | Cantor Fitzgerald | Jennifer Kim | Maintains | OverweightOverweight | Lowers | 5.00 | 4.50 |
How do I buy ProQR Therapeutics (PRQR) stock?
You can purchase shares of ProQR Therapeutics (NASDAQ: PRQR) through any online brokerage.
Who are ProQR Therapeutics's (PRQR) competitors?
There are no as such competitors for ProQR Therapeutics.
What is the target price for ProQR Therapeutics (PRQR) stock?
The latest price target for ProQR Therapeutics (NASDAQ: PRQR) was reported by Citigroup on Monday, September 18, 2023. The analyst firm set a price target for 1.80 expecting PRQR to rise to within 12 months (a possible 22.45% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for ProQR Therapeutics (PRQR)?
The stock price for ProQR Therapeutics (NASDAQ: PRQR) is $1.47 last updated September 22, 2023 at 7:59 PM UTC.
Does ProQR Therapeutics (PRQR) pay a dividend?
There is no dividend information for ProQR Therapeutics.
When is ProQR Therapeutics (NASDAQ:PRQR) reporting earnings?
ProQR Therapeutics’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is ProQR Therapeutics (PRQR) going to split?
There is no upcoming split for ProQR Therapeutics.
What sector and industry does ProQR Therapeutics (PRQR) operate in?
ProQR Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
ProQR Therapeutics Stock (NASDAQ:PRQR), Quotes and News Summary
ProQR Therapeutics Stock (NASDAQ: PRQR) stock price, news, charts, stock research, profile.
| Open1.480 | Close1.470 |
| Vol / Avg.90.293K / 199.782K | Mkt Cap118.982M |
| Day Range1.465 - 1.500 | 52 Wk Range0.725 - 3.850 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.110 | 0.0100 | ||||
| REV | 1.350M | 1.313M | -37.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-18 | Citigroup | Yigal Nochomovitz | Maintains | BuyBuy | Lowers | 2.10 | 1.80 |
| 2023-08-07 | HC Wainwright & Co. | Andrew Fein | Reiterates | BuyBuy | Maintains | - | 5.00 |
| 2023-08-04 | Chardan Capital | Keay Nakae | Reiterates | NeutralNeutral | Maintains | - | 2.00 |
| 2023-05-17 | Cantor Fitzgerald | Jennifer Kim | Maintains | OverweightOverweight | Lowers | 5.00 | 4.50 |
How do I buy ProQR Therapeutics (PRQR) stock?
You can purchase shares of ProQR Therapeutics (NASDAQ: PRQR) through any online brokerage.
Who are ProQR Therapeutics's (PRQR) competitors?
There are no as such competitors for ProQR Therapeutics.
What is the target price for ProQR Therapeutics (PRQR) stock?
The latest price target for ProQR Therapeutics (NASDAQ: PRQR) was reported by Citigroup on Monday, September 18, 2023. The analyst firm set a price target for 1.80 expecting PRQR to rise to within 12 months (a possible 22.45% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for ProQR Therapeutics (PRQR)?
The stock price for ProQR Therapeutics (NASDAQ: PRQR) is $1.47 last updated September 22, 2023 at 7:59 PM UTC.
Does ProQR Therapeutics (PRQR) pay a dividend?
There is no dividend information for ProQR Therapeutics.
When is ProQR Therapeutics (NASDAQ:PRQR) reporting earnings?
ProQR Therapeutics’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is ProQR Therapeutics (PRQR) going to split?
There is no upcoming split for ProQR Therapeutics.
What sector and industry does ProQR Therapeutics (PRQR) operate in?
ProQR Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
ProQR Therapeutics Stock (NASDAQ:PRQR), Quotes and News Summary
ProQR Therapeutics Stock (NASDAQ: PRQR) stock price, news, charts, stock research, profile.
| Open1.480 | Close1.470 |
| Vol / Avg.90.293K / 199.782K | Mkt Cap118.982M |
| Day Range1.465 - 1.500 | 52 Wk Range0.725 - 3.850 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.110 | 0.0100 | ||||
| REV | 1.350M | 1.313M | -37.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-18 | Citigroup | Yigal Nochomovitz | Maintains | BuyBuy | Lowers | 2.10 | 1.80 |
| 2023-08-07 | HC Wainwright & Co. | Andrew Fein | Reiterates | BuyBuy | Maintains | - | 5.00 |
| 2023-08-04 | Chardan Capital | Keay Nakae | Reiterates | NeutralNeutral | Maintains | - | 2.00 |
| 2023-05-17 | Cantor Fitzgerald | Jennifer Kim | Maintains | OverweightOverweight | Lowers | 5.00 | 4.50 |
How do I buy ProQR Therapeutics (PRQR) stock?
You can purchase shares of ProQR Therapeutics (NASDAQ: PRQR) through any online brokerage.
Who are ProQR Therapeutics's (PRQR) competitors?
There are no as such competitors for ProQR Therapeutics.
What is the target price for ProQR Therapeutics (PRQR) stock?
The latest price target for ProQR Therapeutics (NASDAQ: PRQR) was reported by Citigroup on Monday, September 18, 2023. The analyst firm set a price target for 1.80 expecting PRQR to rise to within 12 months (a possible 22.45% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for ProQR Therapeutics (PRQR)?
The stock price for ProQR Therapeutics (NASDAQ: PRQR) is $1.47 last updated September 22, 2023 at 7:59 PM UTC.
Does ProQR Therapeutics (PRQR) pay a dividend?
There is no dividend information for ProQR Therapeutics.
When is ProQR Therapeutics (NASDAQ:PRQR) reporting earnings?
ProQR Therapeutics’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is ProQR Therapeutics (PRQR) going to split?
There is no upcoming split for ProQR Therapeutics.
What sector and industry does ProQR Therapeutics (PRQR) operate in?
ProQR Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
ProQR Therapeutics Stock (NASDAQ:PRQR), Quotes and News Summary
ProQR Therapeutics Stock (NASDAQ: PRQR) stock price, news, charts, stock research, profile.
| Open1.480 | Close1.470 |
| Vol / Avg.90.293K / 199.782K | Mkt Cap118.982M |
| Day Range1.465 - 1.500 | 52 Wk Range0.725 - 3.850 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.110 | 0.0100 | ||||
| REV | 1.350M | 1.313M | -37.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-18 | Citigroup | Yigal Nochomovitz | Maintains | BuyBuy | Lowers | 2.10 | 1.80 |
| 2023-08-07 | HC Wainwright & Co. | Andrew Fein | Reiterates | BuyBuy | Maintains | - | 5.00 |
| 2023-08-04 | Chardan Capital | Keay Nakae | Reiterates | NeutralNeutral | Maintains | - | 2.00 |
| 2023-05-17 | Cantor Fitzgerald | Jennifer Kim | Maintains | OverweightOverweight | Lowers | 5.00 | 4.50 |
How do I buy ProQR Therapeutics (PRQR) stock?
You can purchase shares of ProQR Therapeutics (NASDAQ: PRQR) through any online brokerage.
Who are ProQR Therapeutics's (PRQR) competitors?
There are no as such competitors for ProQR Therapeutics.
What is the target price for ProQR Therapeutics (PRQR) stock?
The latest price target for ProQR Therapeutics (NASDAQ: PRQR) was reported by Citigroup on Monday, September 18, 2023. The analyst firm set a price target for 1.80 expecting PRQR to rise to within 12 months (a possible 22.45% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for ProQR Therapeutics (PRQR)?
The stock price for ProQR Therapeutics (NASDAQ: PRQR) is $1.47 last updated September 22, 2023 at 7:59 PM UTC.
Does ProQR Therapeutics (PRQR) pay a dividend?
There is no dividend information for ProQR Therapeutics.
When is ProQR Therapeutics (NASDAQ:PRQR) reporting earnings?
ProQR Therapeutics’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is ProQR Therapeutics (PRQR) going to split?
There is no upcoming split for ProQR Therapeutics.
What sector and industry does ProQR Therapeutics (PRQR) operate in?
ProQR Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
ProQR Therapeutics Stock (NASDAQ:PRQR), Quotes and News Summary
ProQR Therapeutics Stock (NASDAQ: PRQR) stock price, news, charts, stock research, profile.
| Open1.480 | Close1.470 |
| Vol / Avg.90.293K / 199.782K | Mkt Cap118.982M |
| Day Range1.465 - 1.500 | 52 Wk Range0.725 - 3.850 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.110 | 0.0100 | ||||
| REV | 1.350M | 1.313M | -37.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-18 | Citigroup | Yigal Nochomovitz | Maintains | BuyBuy | Lowers | 2.10 | 1.80 |
| 2023-08-07 | HC Wainwright & Co. | Andrew Fein | Reiterates | BuyBuy | Maintains | - | 5.00 |
| 2023-08-04 | Chardan Capital | Keay Nakae | Reiterates | NeutralNeutral | Maintains | - | 2.00 |
| 2023-05-17 | Cantor Fitzgerald | Jennifer Kim | Maintains | OverweightOverweight | Lowers | 5.00 | 4.50 |
How do I buy ProQR Therapeutics (PRQR) stock?
You can purchase shares of ProQR Therapeutics (NASDAQ: PRQR) through any online brokerage.
Who are ProQR Therapeutics's (PRQR) competitors?
There are no as such competitors for ProQR Therapeutics.
What is the target price for ProQR Therapeutics (PRQR) stock?
The latest price target for ProQR Therapeutics (NASDAQ: PRQR) was reported by Citigroup on Monday, September 18, 2023. The analyst firm set a price target for 1.80 expecting PRQR to rise to within 12 months (a possible 22.45% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for ProQR Therapeutics (PRQR)?
The stock price for ProQR Therapeutics (NASDAQ: PRQR) is $1.47 last updated September 22, 2023 at 7:59 PM UTC.
Does ProQR Therapeutics (PRQR) pay a dividend?
There is no dividend information for ProQR Therapeutics.
When is ProQR Therapeutics (NASDAQ:PRQR) reporting earnings?
ProQR Therapeutics’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is ProQR Therapeutics (PRQR) going to split?
There is no upcoming split for ProQR Therapeutics.
What sector and industry does ProQR Therapeutics (PRQR) operate in?
ProQR Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
ProQR Therapeutics Stock (NASDAQ:PRQR), Quotes and News Summary
ProQR Therapeutics Stock (NASDAQ: PRQR) stock price, news, charts, stock research, profile.
| Open1.480 | Close1.470 |
| Vol / Avg.90.293K / 199.782K | Mkt Cap118.982M |
| Day Range1.465 - 1.500 | 52 Wk Range0.725 - 3.850 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.110 | 0.0100 | ||||
| REV | 1.350M | 1.313M | -37.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-18 | Citigroup | Yigal Nochomovitz | Maintains | BuyBuy | Lowers | 2.10 | 1.80 |
| 2023-08-07 | HC Wainwright & Co. | Andrew Fein | Reiterates | BuyBuy | Maintains | - | 5.00 |
| 2023-08-04 | Chardan Capital | Keay Nakae | Reiterates | NeutralNeutral | Maintains | - | 2.00 |
| 2023-05-17 | Cantor Fitzgerald | Jennifer Kim | Maintains | OverweightOverweight | Lowers | 5.00 | 4.50 |
How do I buy ProQR Therapeutics (PRQR) stock?
You can purchase shares of ProQR Therapeutics (NASDAQ: PRQR) through any online brokerage.
Who are ProQR Therapeutics's (PRQR) competitors?
There are no as such competitors for ProQR Therapeutics.
What is the target price for ProQR Therapeutics (PRQR) stock?
The latest price target for ProQR Therapeutics (NASDAQ: PRQR) was reported by Citigroup on Monday, September 18, 2023. The analyst firm set a price target for 1.80 expecting PRQR to rise to within 12 months (a possible 22.45% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for ProQR Therapeutics (PRQR)?
The stock price for ProQR Therapeutics (NASDAQ: PRQR) is $1.47 last updated September 22, 2023 at 7:59 PM UTC.
Does ProQR Therapeutics (PRQR) pay a dividend?
There is no dividend information for ProQR Therapeutics.
When is ProQR Therapeutics (NASDAQ:PRQR) reporting earnings?
ProQR Therapeutics’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is ProQR Therapeutics (PRQR) going to split?
There is no upcoming split for ProQR Therapeutics.
What sector and industry does ProQR Therapeutics (PRQR) operate in?
ProQR Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
ProQR Therapeutics Stock (NASDAQ:PRQR), Quotes and News Summary
ProQR Therapeutics Stock (NASDAQ: PRQR) stock price, news, charts, stock research, profile.
| Open1.480 | Close1.470 |
| Vol / Avg.90.293K / 199.782K | Mkt Cap118.982M |
| Day Range1.465 - 1.500 | 52 Wk Range0.725 - 3.850 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.110 | 0.0100 | ||||
| REV | 1.350M | 1.313M | -37.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-18 | Citigroup | Yigal Nochomovitz | Maintains | BuyBuy | Lowers | 2.10 | 1.80 |
| 2023-08-07 | HC Wainwright & Co. | Andrew Fein | Reiterates | BuyBuy | Maintains | - | 5.00 |
| 2023-08-04 | Chardan Capital | Keay Nakae | Reiterates | NeutralNeutral | Maintains | - | 2.00 |
| 2023-05-17 | Cantor Fitzgerald | Jennifer Kim | Maintains | OverweightOverweight | Lowers | 5.00 | 4.50 |
How do I buy ProQR Therapeutics (PRQR) stock?
You can purchase shares of ProQR Therapeutics (NASDAQ: PRQR) through any online brokerage.
Who are ProQR Therapeutics's (PRQR) competitors?
There are no as such competitors for ProQR Therapeutics.
What is the target price for ProQR Therapeutics (PRQR) stock?
The latest price target for ProQR Therapeutics (NASDAQ: PRQR) was reported by Citigroup on Monday, September 18, 2023. The analyst firm set a price target for 1.80 expecting PRQR to rise to within 12 months (a possible 22.45% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for ProQR Therapeutics (PRQR)?
The stock price for ProQR Therapeutics (NASDAQ: PRQR) is $1.47 last updated September 22, 2023 at 7:59 PM UTC.
Does ProQR Therapeutics (PRQR) pay a dividend?
There is no dividend information for ProQR Therapeutics.
When is ProQR Therapeutics (NASDAQ:PRQR) reporting earnings?
ProQR Therapeutics’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is ProQR Therapeutics (PRQR) going to split?
There is no upcoming split for ProQR Therapeutics.
What sector and industry does ProQR Therapeutics (PRQR) operate in?
ProQR Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
ProQR Therapeutics Stock (NASDAQ:PRQR), Quotes and News Summary
ProQR Therapeutics Stock (NASDAQ: PRQR) stock price, news, charts, stock research, profile.
| Open1.480 | Close1.470 |
| Vol / Avg.90.293K / 199.782K | Mkt Cap118.982M |
| Day Range1.465 - 1.500 | 52 Wk Range0.725 - 3.850 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.110 | 0.0100 | ||||
| REV | 1.350M | 1.313M | -37.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-18 | Citigroup | Yigal Nochomovitz | Maintains | BuyBuy | Lowers | 2.10 | 1.80 |
| 2023-08-07 | HC Wainwright & Co. | Andrew Fein | Reiterates | BuyBuy | Maintains | - | 5.00 |
| 2023-08-04 | Chardan Capital | Keay Nakae | Reiterates | NeutralNeutral | Maintains | - | 2.00 |
| 2023-05-17 | Cantor Fitzgerald | Jennifer Kim | Maintains | OverweightOverweight | Lowers | 5.00 | 4.50 |
How do I buy ProQR Therapeutics (PRQR) stock?
You can purchase shares of ProQR Therapeutics (NASDAQ: PRQR) through any online brokerage.
Who are ProQR Therapeutics's (PRQR) competitors?
There are no as such competitors for ProQR Therapeutics.
What is the target price for ProQR Therapeutics (PRQR) stock?
The latest price target for ProQR Therapeutics (NASDAQ: PRQR) was reported by Citigroup on Monday, September 18, 2023. The analyst firm set a price target for 1.80 expecting PRQR to rise to within 12 months (a possible 22.45% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for ProQR Therapeutics (PRQR)?
The stock price for ProQR Therapeutics (NASDAQ: PRQR) is $1.47 last updated September 22, 2023 at 7:59 PM UTC.
Does ProQR Therapeutics (PRQR) pay a dividend?
There is no dividend information for ProQR Therapeutics.
When is ProQR Therapeutics (NASDAQ:PRQR) reporting earnings?
ProQR Therapeutics’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is ProQR Therapeutics (PRQR) going to split?
There is no upcoming split for ProQR Therapeutics.
What sector and industry does ProQR Therapeutics (PRQR) operate in?
ProQR Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.